We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Juridica | LSE:JIL | London | Ordinary Share | GG00B29LSW52 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.475 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
03/4/2018 23:14 | It's interesting to look at the respective performance of Juridica and Burford. Scale,due diligence and management expertise all play a part but there are probably many other reasons.I will not speculate as it might be open to litigation! However,I've been here for many years and intend to see it out to the end. | djderry | |
11/1/2018 12:17 | chimers filtered long ago | alter ego | |
11/1/2018 11:53 | troll alert ! | alter ego | |
11/1/2018 11:24 | Thanks for sharing the post Dave. I'd be interested to see the source fro their NAV figure. I think the discount to NAV is wider than they've quoted. | pbanus | |
11/1/2018 10:24 | Liberum; Juridica Investments (Mkt Cap £11m) Aiming to monetise remaining investments in 2018 Event Juridica's portfolio contains two remaining litigation investments which the board believes could generate significant value. The company aims to have these resolved by December 2018. The management fee to be paid for Q1 and Q2 2018 is $125k per quarter (equivalent to c.0.75% of NAV per quarter) and it will be reviewed at the end of Q2. The shares currently trade on an 8.4% discount to NAV. Alter | davebowler | |
10/1/2018 22:09 | In my view it's just a holding statement.I promised I'd tell you something....but not really.Basically,the The timing of the RNS is a bit weird.Did they fear a plunge in the share price if they put it out at the normal time? If it plunges 20 to 30% ,I'll add some more.If not,I'll hang on. | djderry | |
10/1/2018 17:48 | so from memory there were 11 to monetise, so reduced this to 2. Implication of reviewing fund manager fees after Q2-2018 could be they wont be required after then, so looks like optimistically wind up within 6 months, pessimistic view would be 12 months. On balance better than expected given the delay. Would have been good to have an up-to-date NAV. | pbanus | |
10/1/2018 16:09 | I think they'll say, we have the same intention to wind up the fund, but little has changed since last time in terms of realising the investments - hence why no RNS before end Dec. | pbanus | |
10/1/2018 15:49 | Gut feeling, 50/50 | neilyb675 | |
10/1/2018 13:14 | Some buying today! Must be some news coming down the pipeline! | nigelmoat | |
10/1/2018 13:01 | Nice one Neil. Any gut feel about it? | pbanus | |
10/1/2018 12:32 | Just spoke with Camila Hume at Cenkos. Reminded her regards company promise. She is on the case.....keep your eyes peeled. | neilyb675 | |
09/1/2018 14:51 | This is very frustrating. Looks like Vistra Fund Services Ltd look after the administration of Juridica, so perhaps they are worth a call regarding our missing RNS? 01481 726034 | pbanus | |
08/1/2018 17:25 | Hello...tomorrow is the 9th January 2018!!! Did the Co. miss the fact that 2017 has ended. My email to them remains unanswered. Not impressed | plasybryn | |
05/1/2018 20:36 | Yes pretty shabby to still have no promised update. Mr Market was however happy to take a sizeable chunk of my shares today at 10.25 if I had wanted to sell which I read as a favourable indication. Not however interested in selling any as still believe there will be a sizeable premium for those hanging on to the end. All imo/dyor. | nigelmoat | |
05/1/2018 19:02 | Mmmmmmmm. Disappointed that no RNS has been released as per their promise. Must be next week or then must assume the worst.... | neilyb675 |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions